Moderna Series C · $40M raised · (2013)

Moderna, Inc. is a US biotechnology company that develops mRNA-based vaccines and therapeutics. It gained global prominence with the development of mRNA-1273, one of the first authorized COVID-19 vaccines. Beyond COVID, Moderna has a pipeline spanning influenza, RSV, HIV, cancer vaccines, and rare disease treatments. The company generated $19 billion in revenue in 2022.